Controlant raises its CDP rating with progress on climate issues

Controlant continues to drive measurable progress to enable zero-waste pharmaceutical supply chains. The upgraded CDP rating, from B- to B, underscores the company’s dedication to sustainability and its leadership in creating innovative solutions that reduce waste and emissions for the life sciences ecosystem.

Environmental transparency and data-driven action

As part of its commitment to environmental transparency, Controlant made its second annual environmental information submission to the CDP, the global non-profit that runs the world’s leading environmental disclosure platform. It included even more granular data than the previous submission, as CDP constantly raises the bar for what qualifies as environmental leadership.
 
CDP disclosure allows customers, investors, employees, suppliers, and other stakeholders to gain greater insight into factors contributing to Controlant’s improved environmental performance in 2024. Highlights include a reduction in year-on-year global emissions from scopes 1, 2, and 3, and increased usage of renewable energy sources in the company’s operations.

Vicki Preibisch, VP of Sustainability at Controlant:

“Through ESG ratings like CDP, we demonstrate and maintain transparency about our sustainability strategy for the decarbonization of the life sciences ecosystem, while also aligning with shareholder expectations for sustainable business practices. Increased adoption of Controlant’s sustainable solutions and encouraging feedback on our ESG ratings are indicators of successful stakeholder engagement, creating positive change.”

An A for emissions reduction initiatives and low-carbon products 

On a scale from D- to A for environmental leadership and best practice, Controlant scored an A/A- in the categories of scope 3 disclosure, industry collaboration, emissions reduction initiatives, and low carbon products, supported by lifecycle assessment. This year’s rating improvement was further supported by Controlant addressing environmental impact through policies, value chain engagement, and risk and governance processes.
 
The 2024 rating aligns with Controlant’s broader vision for a sustainable life sciences ecosystem, and the feedback from CDP will guide further data-driven actions towards its zero-waste mission. Controlant’s improved CDP rating is a testament to the company’s ongoing efforts to address climate challenges and its role in advancing a sustainable future.

Progress on the path to zero-waste pharma supply chains

By combining innovative technology with actionable data insights, Controlant is helping to transform the pharmaceutical supply chain into a model of environmental responsibility.
 
Controlant helps customers reduce waste and carbon emissions—aligning with global ESG goals. Its solutions and reusable devices help customers transform their supply chains to become more circular, providing environmental transparency and data-driven action.

Gísli Herjólfsson, co-CEO and co-founder at Controlant:

“Controlant collaborates closely with customers to help them lower their environmental impact, particularly by cutting Scope 3 emissions. We work towards our vision of zero-waste pharma supply chains with initiatives such as reusable loggers that replace single-use industry standards, offering both economic and environmental benefits.”

See also: Controlant’s groundbreaking case study by the Carbon Trust in collaboration with Vodafone

About the Climate Disclosure Project

High market demand for environmental disclosure continues to grow. The CDP is now in its 25th year in pioneering climate disclosure with the world’s most comprehensive dataset on environmental action, enabling stakeholders to make Earth-positive decisions.
 
In 2024, over 700 financial institutions representing more than USD 142 trillion in assets requested 33,000 companies, including Controlant, to disclose through CDP. For more information, please visit www.cdp.net.
 
Read more about Controlant's progress on climate issues